Advisor Group’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $2.29M | Buy |
799,846
+23,044
| +3% | +$65.9K | 0.02% | 746 |
|
|
2019
Q3 | $2.85M | Sell |
776,802
-30,373
| -4% | -$111K | 0.02% | 621 |
|
|
2019
Q2 | $3.35M | Buy |
807,175
+114,586
| +17% | +$476K | 0.03% | 550 |
|
|
2019
Q1 | $3.54M | Buy |
692,589
+18,298
| +3% | +$93.5K | 0.03% | 483 |
|
|
2018
Q4 | $2.31M | Buy |
674,291
+76,489
| +13% | +$262K | 0.02% | 579 |
|
|
2018
Q3 | $3.59M | Sell |
597,802
-15,162
| -2% | -$91.1K | 0.04% | 434 |
|
|
2018
Q2 | $3.9M | Buy |
612,964
+56,587
| +10% | +$360K | 0.05% | 316 |
|
|
2018
Q1 | $2.64M | Buy |
556,377
+25,527
| +5% | +$121K | 0.04% | 454 |
|
|
2017
Q4 | $1.77M | Buy |
530,850
+11,000
| +2% | +$36.7K | 0.02% | 605 |
|
|
2017
Q3 | $1.11M | Buy |
519,850
+35,850
| +7% | +$76.7K | 0.02% | 742 |
|
|
2017
Q2 | $1.19M | Buy |
484,000
+45,700
| +10% | +$112K | 0.02% | 666 |
|
|
2017
Q1 | $1.01M | Buy |
438,300
+67,475
| +18% | +$155K | 0.02% | 704 |
|
|
2016
Q4 | $363K | Sell |
370,825
-42,300
| -10% | -$41.4K | 0.01% | 1188 |
|
|
2016
Q3 | $467K | Buy |
413,125
+15,200
| +4% | +$17.2K | 0.01% | 1009 |
|
|
2016
Q2 | $584K | Buy |
+397,925
| New | +$584K | 0.02% | 840 |
|